Results 131 to 140 of about 3,203,567 (223)

Underutilization of Injectable Parkinson's Disease Medication: An Analysis of Neurologist and Patient Perspectives. [PDF]

Mov Disord Clin Pract
Solis G, Patierno J, Rossol J, Kumar R.
europepmc   +1 more source

Levodopa-entacapone-carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease. [PDF]

Eur J Neurol
Öthman M, Bergquist F, Odin P, Scharfenort M, Johansson A, Markaki I, Svenningsson P, Dizdar N, Nyholm D.   +8 more
europepmc   +1 more source

The costs and benefits of deep brain stimulation in Parkinson's disease: a review and social network analysis. [PDF]

Arq Neuropsiquiatr
Zúñiga-Ramírez C, Farías-Moreno KC, Moreno G, Gómez-Figueroa E, Caicedo-Ortíz HE, Carrillo-Ruíz JD.   +5 more
europepmc   +1 more source

Association of Medication Use and 8-Year Mortality Risk in Patients With Parkinson Disease: Drug-Wide Trial Emulation. [PDF]

Neurology
Tuominen JA, Riise T, Romanowska J, Flores-Torres MH, Cortese M, Scherzer CR, Bjornevik K, Igland J.   +7 more
europepmc   +1 more source

Exploring the risk of adverse drug events in combination with antiparkinsonics and antipsychotics-a two-decade real-world pharmacovigilance analysis based on the FAERS database. [PDF]

Int J Neuropsychopharmacol
Wang J, Lin S, Bai C, Zhang H, Liu H, Wang M, Guo R.   +6 more
europepmc   +1 more source

Personalized medication recommendations for Parkinson's disease patients using gated recurrent units and SHAP interpretability. [PDF]

Sci Rep
Riasi A, Delrobaei M, Salari M.
europepmc   +1 more source

[More about antiparkinson agents].

Psychiatria polska, 1982
openaire   +1 more source

[1 model for the prognosis of anticonvulsive and antiparkinson agents].

Farmatsevtychnyi zhurnal, 1979
N O, Ianishevs'ka, R M, Piniazhko
openaire   +1 more source

[Abuse of the antiparkinson agents biperidin and benzhexol].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1983
openaire   +1 more source

New L‐Dopa Codrugs as Potential Antiparkinson Agents

Archiv der Pharmazie, 2008
AbstractThis paper reports the synthesis and preliminary evaluation of newL‐dopa (LD) conjugates (1and2) obtained by joining LD with two different natural antioxidants, caffeic acid and carnosine, respectively. The antioxidant efficacy of compounds1and2was assessed by evaluating plasmatic activities of superoxide dismutase (SOD) and glutathione ...
Piera Sozio, Antonio Iannitelli, Laura Serafina Cerasa, Ivana Cacciatore, Catia Cornacchia, Gianfabio Giorgioni, Massimo Ricciutelli, Cinzia Nasuti, Franco Cantalamessa, Antonio Di Stefano   +9 more
semanticscholar   +7 more sources